Maxim Group Downgrades MYnd Analytics (MYND) to Hold

MYnd Analytics (NASDAQ:MYND) was downgraded by analysts at Maxim Group to a “hold” rating in a research report issued on Tuesday.

Shares of MYnd Analytics (NASDAQ:MYND) traded down $0.25 during trading on Tuesday, hitting $2.44. The stock had a trading volume of 4,000 shares, compared to its average volume of 10,814. MYnd Analytics has a 12-month low of $2.22 and a 12-month high of $8.25.

In other news, Director John Pappajohn acquired 10,000 shares of MYnd Analytics stock in a transaction dated Friday, January 5th. The shares were purchased at an average cost of $3.44 per share, for a total transaction of $34,400.00. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Peter Unanue acquired 15,000 shares of MYnd Analytics stock in a transaction dated Wednesday, December 6th. The shares were purchased at an average price of $3.65 per share, for a total transaction of $54,750.00. The disclosure for this purchase can be found here. 17.81% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION NOTICE: “Maxim Group Downgrades MYnd Analytics (MYND) to Hold” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this report can be read at https://www.americanbankingnews.com/2018/02/13/maxim-group-downgrades-mynd-analytics-mynd-to-hold.html.

About MYnd Analytics

MYnd Analytics, Inc, formerly CNS Response, Inc, is a predictive analytics company. The Company has developed a decision support tool to help physicians reduce trial and error treatment in mental health, and provide personalized care to patients. The Company provides objective clinical decision support to mental healthcare providers for the personalized treatment of behavioral disorders, including depression, anxiety, bipolar disorder, post-traumatic stress disorder (PTSD) and other non-psychotic disorders.

Receive News & Ratings for MYnd Analytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MYnd Analytics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply